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408ABSTRACT
Background. Organ transplant recipients frequently have chronic inﬂammation, with
a weighty impact on cardiovascular risk. These patients can beneﬁt from exercise, although
the role of intense training is unclear. We evaluated the effect of a 130-km cycling race on
inﬂammatory cytokines and adiponectin levels in transplant recipients.
Methods. Circulating interleukin (IL)-6, tumor necrosis factor (TNF)-a, interferon
(IFN)-g, and adiponectin were assayed in 35 healthy subjects vs 19 transplant recipients
(10 kidney, 8 liver, 1 heart), matched for sex, age, body mass index, and preparation
workout. The determinations were performed before the race, at the end, and after 18 to
24 hours. Baseline values of 32 sedentary transplant recipients also were evaluated
to explore the possible chronic impact of lifestyle.
Results. All cyclists had 6- to 8-fold increased IL-6 levels after the race that decreased,
without returning to baseline, the day after. Conversely, serum TNF-a and IFN-g
showed a progressive increase starting during physical performance and enduring for the
next 18 to 24 hours in healthy subjects, whereas they were unchanged over time in
cyclists with transplants. In transplant recipients who did not perform exercise, all of the
analytes were signiﬁcantly higher in comparison to basal levels of physically active subjects.
Conclusions. Our data suggest that clinically stable and properly trained transplant
recipients can safely perform and progressively beneﬁt from exercise, even at a competitive
level. The changes in inﬂammation parameters were temporary and parallel with those of
the healthy subjects. The comparison with sedentary transplant recipients revealed an
overall amelioration of inﬂammatory indexes as a possible effect of regular physical activity
on systemic inﬂammation.This paper is dedicated to the memory of Jonah Lomu, a sport
champion, a rugby legend and a kidney transplant recipient.
*Address correspondence to Alessandro Nanni Costa, Italian
National Transplant Centre, Istituto Superiore di Sanità, viale
Regina Elena 299, 00161 Rome, Italy. E-mail: daniela.storani@
iss.itPHYSICAL activity has been proven to have manyimportant positive cardiovascular effects in the general
population [1]. In the last few years, accumulating evidence
has suggested that patients with solid organ transplants can
also beneﬁt from regular exercise, especially for the pre-
vention of cardiovascular disease, osteoporosis, and joint
and bone pathology, and for the recovery of physical ability
and psychological wellbeing [2e6]. In 2008, the Italian
National Transplant Centre launched the project “Trans-
plant. and now Sport” aimed to spread the awareness of
the importance of physical activity in organ transplant6
.org/10.1016/j.transproceed.2016.02.001recipients. The project developed a model of cooperation
between transplantation doctors, sports physicians, physical
education specialists, and patient associations, such asª 2016 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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Table 1. Demographic Characteristics and Biochemical,
Therapeutic, and Transplant-Related Parameters
Healthy
Cyclists at
Baseline
(n ¼ 35)
Transplanted
Cyclists at
Baseline
(n ¼ 19)
Sedentary
Transplant
Recipients
(n ¼ 32)
Age, y 50.0  10.0 52.1  9.0 54.5  7.4
Body mass index, kg/m2 24.1  2.3 23.7  1.7 24.8  3.2
Systolic blood pressure,
mm Hg
120  14 130  12 135  11
Diastolic blood pressure,
mm Hg
80  7 86  8 83  6
Transplanted organ
Single kidney 10 32
Liver 8 0
Heart 1 0
Type of organ donation (kidney)
Cadaveric/living 9/1 27/5
Time from transplant, y 9.3  5.1 7.4  6.6
Serum creatinine, mg/dL 0.96  0.13 1.43  0.90 1.66  0.70
Estimated glomerular
ﬁltration rate, mL/min/
1.73 m2
90.7  27.4 72.4  26.0 61.4  23.7
Immunosuppressive therapy
Tacrolimus/cyclosporine 15 24
Steroids 8 14
Mycophenolic acid 8 12
Everolimus 4 7
Antihypertensive therapy
Angiotensin-converting
enzyme inhibitors
1 7 12
b-blockers 0 7 11
Calcium channel blockers 0 1 2
Acute rejection episodes,
number (%)
2 (10.5%) 4 (12.5%)
Previous malignancy,
number (%)
1 (5.3%) 2 (6.2%)
Continuous variables are expressed as media  standard deviation, cate-
gorical variables as absolute numbers or percentages.
INFLAMMATORY AND ADIPOSE RESPONSE AFTER A RACE 409ANED (Associazione Nazionale Emodializzati, Dialisi e
Trapianto). The research plan is focused on the concept of
exercise as a nonpharmacological therapy to be adminis-
tered using a patient-tailored approach, able to counteract
some common posttransplantation complications frequently
associated with chronic subclinical inﬂammation. Previous
results from the project have indicated that regular physical
activity is able to bring signiﬁcant beneﬁts to the clinical,
physiological, and psychological status of organ transplant
recipients [4e7]. However, little is known about the exercise
load and intensity level that may be safely applicable to the
transplant population. Recently we evaluated the effects of
a 130-km road cycling race (“Novecolli Life” project) on the
changes in renal function parameters in solid organ trans-
plant recipients. Our data showed a transient increase of
serum creatinine and proteinuria immediately after the end
of the race and a successive rapid decline to the baseline
levels measured at rest in the following 18 to 24 hours [5].
Given the role of inﬂammation in atherosclerosis and
cardiovascular risk after transplantation, we investigated the
impact of the same long-distance road cycling competition
on the inﬂammatory cytokines interleukin (IL)-6, tumor
necrosis factor (TNF)-a, interferon (IFN)-g, and adipo-
nectin in kidney, liver, and heart transplant recipients
compared with healthy control subjects.
MATERIALS AND METHODS
Subjects
This study recruited 35 healthy subjects and 19 organ transplant
recipients, all male, to participate in the short route of the Nove
Colli road cycling race held in the Romagna region of Italy. The
path covered by the participants was 130 km, including 4 hills with
1871 meters of altitude drop. The maximum riding time allowed was
7.5 hours, respecting an overall average not exceeding 25 km/h.
The healthy control subjects were leisure and amateur cyclists
invited by the organization of the competition through a newsletter.
They were between 18 and 72 years old, normal weight, and
normotensive, except one of them who was under angiotensin-
converting enzyme inhibitor treatment (Table 1). Each subject
who agreed to take part in the study provided a medical certiﬁcate
of ﬁtness for participation in competitive cycling events.
The group of organ transplant patients, enrolled with the support
of ANED Sport, consisted of 10 kidney recipients, 8 liver recipients,
and 1 heart recipient. All of them voluntarily decided to participate
in the race, were between 18 and 72.9 years old, were of normal
weight, were at least 1 year posttransplantation with stable renal
function (Table 1), and had previous physical preparation through
usual practice of road cycling. They had gone through a preliminary
evaluation for their eligibility to undertake structured programs of
physical activity, according to an algorithm based on ergometric and
cardiac function tests for assessing the likelihood of cardiovascular
events (detection of eventual silent heart disease), and personali-
zation of exercise loads [7]. The immunosuppressive regimen was
calcineurin inhibitors in 15 patients, in 8 of them associated with
steroid therapy, inhibitors of DNA synthesis in 8 patients, and
mTOR inhibitors in 4 patients. They had good blood pressure
control achieved by treatment with angiotensin-converting enzyme
inhibitors, beta-blocker therapy, or calcium channel blockers
(Table 1). Only 1 patient experienced posttransplantationmalignancy. None of the participants in both groups had diabetes
mellitus or major cardiovascular events in the 2-year period prior to
enrolment.
The study was carried out in accordance with the Declaration of
Helsinki, the ICH (International Council on Harmonisation of
Technical Requirements for Registration of Pharmaceuticals for
Human Use) Guidelines for Good Clinical Practice, and national
rules and regulations regarding clinical research. A written
informed consent was obtained before inclusion, in accordance with
the procedures approved by the Ethical Committees of the Italian
Institute of Health.Study Design
All subjects who took part in the study underwent a preliminary
overall evaluation consisting of (1) physical examination including
measurement of blood pressure and resting heart rate, (2) data
collection for anamnesis, clinical history, and information on drug
therapies, (3) administration of a questionnaire to assess subjective
perceptions of the Health-Related Quality of Life with the SF-36, as
previously described in detail by our group [6], along with the
preparation training schedule followed during the year. The
Table 2. Levels of Circulating Inﬂammatory Cytokines TNF-a,
IL-6, and IFN-g in Healthy Subjects and Organ-Transplanted
Cyclists at Three Different Time Points
Median [IQR1eIQR3] P Value
Healthy cyclists (n ¼ 35)
IL-6, pg/mL
T1 2.17 [1.62e2.91] <.001*
T2 16.70 [9.54e25.05]
T3 3.26 [2.64e6.35]
TNF-a, pg/mL
T1 10.32 [9.63e14.12] <.001†
T2 12.52 [11.09e14]
T3 12.60 [11.09e15.49]
IFN-g, pg/mL
T1 191.01 [182.05e208.65] <.001†
T2 220.1 [201.90e231.18]
T3 211.08 [194.90e241.95]
Transplanted cyclists (n ¼ 19)
IL-6, pg/mL
T1 3.10 [2.54e5.11] <.001*
T2 16.97 [8.09e25.42]
T3 6.29 [3.52e12.28]
TNF-a, pg/mL
T1 20.12 [11.72e26.43] NS
T2 14.00 [12.93e26.86]
T3 17.61 [11.09e32.36]
IFN-g, pg/mL
T1 204.26 [190.96e212.99] NS
T2 220.03 [201.9e228.99]
T3 248.11 [201.90e294.33]
Data are given as median and IQR. Changes in cytokine levels over time were
assessed using a Friedman test, with the limit for statistical signiﬁcance set at
P < .05.
Abbreviations: TNF-a, tumor necrosis factor alpha; IL-6, interleukin 6; IFN-g,
interferon gamma; IQR, interquartile range; T1, day before the race; T2, imme-
diately after the race; T3, 18 to 24 hours after the race.
*T1<T3<T2.
†T1<T2,T3.
410 CAPPUCCILLI, MOSCONI, ROI ET ALexperimental protocol included specimen collection at 3 time
points: the day before the race (T1), immediately after the race
(T2), and 18 to 24 hours after the race (T3). Additionally, the total
volume of ﬂuid ingested and the possible occurrence of adverse
events also were recorded.
To investigate the chronic effects of exercise on inﬂammatory
status, we successively recruited a third group of 32 kidney trans-
plant recipients with a sedentary lifestyle matched for sex (all male),
age, body mass index (BMI), time from transplantation, blood
pressure, distribution of immunosuppressive therapy, and frequency
of major posttransplantation complications (Table 1), and then
compared their circulating levels of cytokines and adiponectin with
those measured at the baseline (T1) of the physically active subjects
(healthy control subjects and transplant patients) who had partici-
pated in the race.
Luminex Analysis of Inﬂammatory Cytokines and
Adiponectin
Blood samples were collected in BD Vacutainer clot activator
tubes, centrifuged at 1500 g for 15 minutes within 4 hours of
venipuncture, and sera were kept at frozen at 70C until analysis.
A multiplex assay was carried out for the simultaneous quantiﬁca-
tion of serum cytokines (IL-6, TNF-a, and IFN-g) and adiponectin
using commercially available kits (MILLIPLEX MAP Human
Cytokine/Chemokine Magnetic Bead Panel, catalog #HCYTO-
MAG-60K, kit lot #2423458; MILLIPLEX MAP Human Adipo-
kine Magnetic Bead Panel 1, catalog #HADK1MAG-61K, kit lot
#2423457, Millipore Corp., Billerica, MA), according to the
manufacturer’s instructions. Determination of cytokines and adi-
ponectin were done in 2 separate experimental sessions because of
the orders of magnitude differences in the expected concentration
ranges (pg/mL for cytokines and mg/mL for adiponectin). The assay
sensitivities (minimum detectable concentrations) were 0.9 pg/mL
for IL-6, 0.7 pg/mL for TNF-a, 0.8 pg/mL for IFN-g, and 11 pg/mL
for adiponectin. The coefﬁcients of variation (CV%) were as
follows: 2.0% intra-assay and 18.3% interassay for IL-6, 2.6% intra-
assay and 13.0% interassay for TNF-a, 1.6% intra-assay and 12.0%
interassay for IFN-g, 4% intra-assay and 10% interassay for
adiponectin. Concentrations were calculated using a 7-point stan-
dard curve obtained by serial dilutions, and ﬁnally the plates were
read on the Luminex MAGPIX system (Luminex, Austin, TX), and
data were analyzed through the Analyst 5.1 PLUS software
(Millipore).
Statistical Analysis
Continuous variables are given as mean  standard deviation if
normally distributed or median with interquartile range if non-
normally distributed. For the evaluation of the acute effects of
physical exercise, the changes in circulating cytokine levels over
time (baseline T1 vs T2 and T3) were computed in each group using
a Friedman test. Differences between healthy subjects and trans-
planted cyclists at each time were then analyzed by means of
nonparametric Mann-Whitney U test. For examining the variations
related to the chronic effects of sport on inﬂammatory and adipose
response, the values at baseline (T1) of circulating IL-6, TNF-a,
IFN-g, and adiponectin in healthy and transplanted cyclists were
compared with those of the group of sedentary transplant recipients
using Kruskal-Wallis test, followed by a Tukey test to check for
pairwise differences between the groups. Multiple linear regression
analysis was used to evaluate the correlations between age, BMI
and blood pressure and the serum markers of inﬂammatory andadipose response, after adjusting for laboratory test variables.
Analysis was conducted using the SPSS (IBM SPSS Statistics,
version 20.0; SPSS Inc., Chicago, IL). A 2-sided value of P < .05 was
regarded as statistically signiﬁcant.RESULTS
All participants completed the route within comparable
times (average about 6 hours) without reporting adverse
events during or after the race. Likewise, there were no
signiﬁcant differences in the total ﬂuid volume ingested
throughout the competition (2533  1067 mL vs 1957  652
mL; P ¼ NS) and in the amount of previous preparation
training, expressed as number of workout sessions per week
and exercise duration for each session.
Acute Effects of Exercise on Inﬂammatory Cytokine Levels
Table 2 reports the results of the Friedman test for the
comparison within each group of serum levels of inﬂam-
matory cytokines IL-6, TNF-a, and IFN-g at the different
times: T1 vs T2 vs T3. Table 3 illustrates the differences
assessed using a Mann-Whitney U test in circulating
Table 3. Levels of Circulating Inﬂammatory Cytokines TNF-a,
IL-6, and IFN-g in Healthy Subjects vs Organ-Transplanted
Cyclists at Three Different Time Points
Healthy Cyclists (n ¼ 35) Transplanted Cyclists (n ¼ 19)
P ValueMedian [IQR1-IQR3] Median [IQR1-IQR3]
IL-6, pg/mL
T1 2.17 [1.62e2.91] 3.10 [2.54e5.11] .002
T2 16.70 [9.54e25.05] 16.97 [8.09e25.42] NS
T3 3.26 [2.64e6.35] 6.29 [3.52e12.28] .049
TNF-a, pg/mL
T1 10.32 [9.63e14.12] 20.12 [11.72e26.43] <.001
T2 12.52 [11.09e14] 14.00 [12.93e26.86] .016
T3 12.60 [11.09e15.49] 17.61 [11.09e32.36] NS
IFN-g, pg/mL
T1 191.01 [182.05e208.65] 204.26 [190.96e212.99] NS
T2 220.1 [201.90e231.18] 220.03 [201.9e228.99] NS
T3 211.08 [194.90e241.95] 248.11 [201.90e294.33] NS
Data are given as median and IQR, and the differences in cytokine levels
between the 2 groups at each time point were assessed using a Mann-Whitney
U test, with the limit for statistical signiﬁcance set at P < .05.
Abbreviations: TNF-a, tumor necrosis factor alpha; IL-6, interleukin 6; IFN-g,
interferon gamma; IQR, interquartile range; T1, day before the race; T2, imme-
diately after the race; T3, 18 to 24 hours after the race.
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planted cyclists) for each time point: T1, T2, and T3.
IL-6 serum levels were found to be 6- to 8-fold increased
in both healthy subjects and transplanted cyclists immedi-
ately after the race (to a higher extent in the healthy
subjects), and then declined, without returning to the
baseline levels, within the following 18 to 24 hours
(Table 2). The comparison between groups at the different
times, shown in Table 3, revealed signiﬁcantly higher IL-6
values in transplanted cyclists at T1 (P ¼ .002) and T3
(P ¼ .049). Circulating TNF-a levels displayed a progressive
increase over time (T1 < T2 < T3, P < .001) in the healthy
subjects, whereas they remained quite stable in transplant
recipients (P ¼ NS) (Table 2). However, TNF-a levels were
higher in the transplanted cyclists compared to the healthy
ones at each experimental time, but not signiﬁcantly at T3
(T1: P ¼ <.001; T2: P ¼ .016; T3: P ¼ NS) (Table 3).
Similarly, serum IFN-g showed increasing values in the
healthy subjects starting during the physical performance
and enduring 18 to 24 hours after the end of marathon
cycling (T1 < T2 < T3, P < .001). Conversely, theTable 4. Levels of Circulating Inﬂammatory Cytokines TNF-a, IL-6, I
Transplanted Cyclists at Baseline vs
A. Healthy Cyclists at Baseline
(n ¼ 35)
B. Transplanted
(n
Median [IQR1eIQR3] Median
IL-6, pg/mL 2.17 [1.62e2.91] 3.10
TNF-a, pg/mL 10.32 [9.63e14.12] 20.12 [
IFN-g, pg/mL 191.01 [182.05e208.65] 204.26 [1
Adiponectin, mg/mL 3.97 [3.03e7.35] 3.92
Data are given as median and IQR. The differences in cytokine levels among the 3
statistical signiﬁcance set at P < .05.
Abbreviations: TNF-a, tumor necrosis factor alpha; IL-6, interleukin 6; IFN-g, interf
*A<B,C.
†A,B<C.transplanted patients had no signiﬁcant variations in IFN-g
levels related to the physical performance. When comparing
the 2 groups of cyclists at the different times (Table 3), the
concentration of circulating IFN-g did not differ signiﬁ-
cantly in the healthy subjects vs transplant recipients at T1,
T2, and T3 (P ¼ NS).
Chronic Effects of Exercise on Inﬂammatory Cytokine and
Adiponectin Level
The chronic effects of exercise on inﬂammatory and adipose
response were investigated comparing the values at baseline
(T1) of circulating IL-6, TNF-a, IFN-g, and adiponectin in
the 2 groups of physically active subjects who participated
in the race with a matched group of 32 sedentary trans-
planted patients. Table 4 reports the results of the Kruskal-
Wallis test used to analyze the differences between the
3 groups. Signiﬁcantly higher levels of circulating IL-6,
TNF-a, and IFN-g and serum adiponectin were found in
sedentary transplant recipients in comparison to the values
measured at baseline in healthy and transplanted cyclists
(for IL-6, TNF-a, and IFN-g, P < .001; for adiponectin,
P ¼ .030).
Correlation of Age, BMI and Blood Pressure with Cytokine
and Adiponectin Serum Level
For each group, multiple linear regression analyses were
performed to assess the possible correlations of age, BMI,
and blood pressure with each serum marker of inﬂammatory
and adipose response as dependent variables. As expected,
in the healthy cyclists higher BMI values correlated nega-
tively with adiponectin levels and positively with IL-6
(r ¼ 0.232, P ¼ .045; r ¼ 0.240, P ¼ .039, respectively),
even after adjusting all clinical parameters tested (Fig 1).
Likewise, it was observed that in the physically active
transplant recipients who participated in the race, BMI was
inversely correlated with serum adiponectin values
(r ¼ 0.571, P ¼ .021) (Fig 1C).
DISCUSSION
This study was undertaken in the framework of a broader
project, named “Transplant. and now Sport”, aimed to
encourage physical exercise after transplantation. TheFN-g, and Adiponectin Levels in Healthy Cyclists at Baseline vs
Sedentary Transplant Recipients
Cyclists at Baseline
¼ 19)
C. Sedentary Transplant Recipients
(n ¼ 32)
P Value[IQR1eIQR3] Median [IQR1eIQR3]
[2.54e5.11] 8.75 [6.98e11.86] <.001*
11.72e26.43] 37.18 [20.11e85.53] <.001*
90.96e212.99] 287.44 [266.47e294.33] <.001†
[2.34e5.7] 13.09 [6.37e25.49] .030†
groups at each time were assessed using a Kruskal-Wallis test, with the limit for
eron gamma; IQR, interquartile range.
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Fig 1. Scatter plots and regression line showing the signiﬁcant correlations between (A) body mass index (BMI) and interleukin (IL)-6
levels in healthy cyclists; (B) BMI and adiponectin levels in healthy cyclists; (C) BMI and adiponectin levels in transplanted cyclists. In (A),
r ¼ 0.232, P ¼ .045; in (B), r ¼ 0.240, P ¼ .039; in (C), r ¼ 0.571, P ¼ .021.
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high-intensity exercise can be safely performed by trans-
planted patients if properly trained and clinically stable. We
evaluated the impact of a 130-km road cycling race on in-
ﬂammatory cytokines and adiponectin in kidney, liver, and
heart transplant recipients. The current concept indicates
inﬂammation as the main driving force underlying the
pathogenesis of cardiovascular disease, which over recent
decades has become the most frequent among the known
causes of death after organ transplantation [8,9]. The
elevated cardiovascular burden of transplant recipients is
feasibly related to the progressive accumulation of athero-
genic risk factors during the clinical history of these patients.
In addition, after organ transplant a further contribution to
the overall cardiovascular risk is given by the chronic use of
some immunosuppressive drugs having a negative impact on
some common cardiovascular risk factors, such as diabetes,
hypertension, hyperlipidemia [10].
Despite the acknowledged effects of regular physical ac-
tivity in reducing chronic low-grade inﬂammation [11], in
the short-term, prolonged exercise (>2.5 hours) is known to
elicit the release of inﬂammatory mediators into thebloodstream, particularly IL-6 and C-reactive protein
[12,13]. Our data on the acute effects of the physical per-
formance on IL-6 levels revealed a comparable course
between healthy and transplanted cyclists, although the
latter displayed higher serum values at each time point,
perhaps because of a different baseline clinical condition.
The parallel trend observed in both groups, reaching a
zenith immediately after the race followed by a rapid
decline in the successive 18 to 24 hours, is consistent with a
number of studies reporting that IL-6 is the ﬁrst cytokine to
appear in the circulation during and immediately after
exercise: this increase has been minimally attributed to
proliferation/mobilization of neutrophils and monocytes
[14], and increased production by adipose tissue [15], brain
[16], and peritendon tissue [17]. Actually it was ﬁrstly re-
ported several years ago that the contracting skeletal muscle
is the major contributor of exercise-induced release of
speciﬁc cytokines, called myokines [18]. This hypothesis is
also corroborated by an experimental model on horses that
revealed an activation of proﬂogistic cytokine genes,
including IL-6, TNF-a, and IFN-g in muscle biopsies
collected immediately after exercise and at 0.5, 1, 2, 6, and
INFLAMMATORY AND ADIPOSE RESPONSE AFTER A RACE 41324 hours after incremental loads of workout [19]. It has
been proposed that the initial trigger for the IL-6 upregu-
lation is a drop in muscle glycogen content, together with an
increase in intracellular calcium levels and formation of
reactive oxygen species [13]. The release of IL-6 into the
circulation during exercise induces either an increase in
serum levels of anti-inﬂammatory cytokines IL-10 and IL-1
receptor antagonist (IL-1RA), or the release of cortisol
from the adrenal glands, which may signify an adaptation to
stress upon resolution of inﬂammation [20]. The impact of
acute exercise on TNF-a and IFN-g is less clear in the
general population, and to the best of our knowledge, there
are no available studies to date in transplant recipients. In
our transplanted cyclists, both cytokines remained quite
unchanged during and after the physical performance,
whereas the healthy subjects showed a trend toward an
increase over time starting with the race and enduring for
the next 18 to 24 hours. A study by Ostroswki et al. on
cytokine response to strenuous physical activity during the
Copenhagen marathon reported an increase of circulating
pro-inﬂammatory cytokines IL-6, TNF-a, and IL-1b, coun-
teracted by a compensatory release of cytokine inhibitors
(IL-1ra, sTNF-r1, and sTNF-r2) and the anti-inﬂammatory
cytokine IL-10, which may be viewed as a mechanism of
defense against exercise-induced myocyte injury [21]. The
analogous variations over time of IL-6 levels in healthy and
transplanted cyclists might indicate that chronic immuno-
suppression does not impair this protective mechanism of
IL-6 gene activation with the subsequent anti-inﬂammatory
cascade in physically active transplant recipients. On the
other hand, our ﬁndings on the different behavior of TNF-a
and IFN-g between the 2 groups of cyclists are more difﬁ-
cult to interpret, and the relatively small number of patients
prevents us from drawing any ﬁrm conclusions about a
possible attenuated cytokine response in transplant re-
cipients. Moreover, in our protocol the anti-inﬂammatory
cytokines were not assayed, and this might represent a
limitation in the current study design that needs to be
addressed in the future.
A further interesting ﬁnding emerged from the evaluation
of chronic effects of regular physical exercise when we
compared the baseline values of inﬂammatory cytokines and
adiponectin in the healthy and transplanted subjects who
participated in the race with those of a matched group of
sedentary transplanted patients. All serum parameters
analyzed were found to be signiﬁcantly increased in trans-
plant recipients who did not perform any regular exercise in
comparison to both groups of physically active subjects. For
cytokine proﬁles, our observation agrees with current
knowledge based on several previous studies, proving an
association between physical inactivity and low-grade sys-
temic inﬂammation in different populations: healthy sub-
jects as well as patients with one or more cardiovascular risk
factors [22,23]. Different mechanisms have been proposed
to explicate the antiﬂogistic effects of regular exercise, and
feasibly one key contributor in promoting a beneﬁcial
environment is the reduction in visceral fat mass, which isgenerally accompanied by an increase in anti-inﬂammatory
adipokines [24]. Our ﬁndings are only partially in line with
this model because in spite of the signiﬁcant reduction of all
inﬂammatory cytokines in physically active subjects, they
unexpectedly revealed lower adiponectin levels in compar-
ison to sedentary transplant recipients. Adiponectin is an
adipokine generally known to have protective features in
cardiovascular homeostasis, and has been inversely associ-
ated with visceral adipose tissue and the risk of insulin
resistance, diabetes, and metabolic syndrome [25]. Studies
in animals and humans have proven that 3 weeks or more of
regular exercise is needed to induce upregulation of adi-
ponectin and adiponectin receptor 1 genes in adipose tissue,
whereas acute physical efforts do not seem to affect their
mRNA expression in the short term [26,27]. For this reason,
we did not observe signiﬁcant changes in circulating
adiponectin levels during or after the race, thus the data
concerning the acute effects of exercise on adiponectin have
not been described here. Indeed, in both groups of cyclists,
the healthy and the transplanted, higher BMI values
correlated negatively with adiponectin levels, but we did not
ﬁnd this association in sedentary transplant recipients, who
also showed surprisingly high adiponectin serum levels. This
puzzling result might be explained in the light of more
recent scientiﬁc evidence that seems to controvert the role
of adiponectin as a protective cardiovascular molecule [25].
Although this paradigm seems to be valid for the general
adult and middle-aged population, in the last decade
accumulating epidemiological data have introduced the
“adiponectin paradox”, supporting the contrasting hypoth-
esis that high circulating adiponectin levels are independent
predictors of cardiovascular events in speciﬁc categories of
patients at increased cardiovascular risk [28].
In conclusion, this study suggests that transplanted
patients in good clinical condition, with a well-tolerated
immunosuppressive therapy and proper training, can
beneﬁt from physical activity, even at a competitive level.
Marathon cycling induced some changes in inﬂammation
parameters that were transient and superimposable between
physically active healthy and transplanted cyclists. The
comparison with sedentary transplant recipients revealed a
signiﬁcant lowering in the circulating concentrations of
certain proﬂogistic indexes as a possible effect of sporting
activities on systemic inﬂammation.REFERENCES
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